Supporting patients with haemophilia in a world of crises: New role for the WFH and its partners

Glenn F Pierce¹, Assad Haffar¹, Alain Baumann¹, Cedric Hermans^{1

2}

Affiliations

¹ World Federation of Haemophilia, Montreal, Canada.
² Division of Haematology, Haemostasis and Thrombosis Unit, Saint-Luc University Hospital, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Editorial

Glenn F Pierce et al. Haemophilia. 2022 Jul.

. 2022 Jul;28(4):521-522.

doi: 10.1111/hae.14610.

Glenn F Pierce¹, Assad Haffar¹, Alain Baumann¹, Cedric Hermans^{1

2}

¹ World Federation of Haemophilia, Montreal, Canada.
² Division of Haematology, Haemostasis and Thrombosis Unit, Saint-Luc University Hospital, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

No abstract available

References

1. Berntorp E, Fischer K, Hart DP, et al. Haemophilia. Nat Rev Dis Primers. 2021;7(1):45.
1. Mannucci PM. Hemophilia therapy: the future has begun. Haematologica. 2020;105(3):545-553.
1. Ozelo MC, Yamaguti-Hayakawa GG. Impact of novel hemophilia therapies around the world. Res Pract Thromb Haemost. 2022;6(3):e12695.
1. Batty P, Lillicrap D. Hemophilia gene therapy: approaching the first licensed product. Hemasphere. 2021;5(3):e540.
1. Stonebraker JS, Bolton-Maggs PHB, Brooker M, et al. The World Federation of Hemophilia Annual Global Survey 1999-2018. Haemophilia. 2020;26(4):591-600.